Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Am J Respir Cell Mol Biol ; 67(1): 76-88, 2022 07.
Article in English | MEDLINE | ID: mdl-35507773

ABSTRACT

Alpha-1 antitrypsin deficiency (AATD) is characterized by neutrophil-dominated inflammation resulting in emphysema. The cholesterol-rich neutrophil outer plasma membrane plays a central role in adhesion and subsequent transmigration to underlying tissues. This study aimed to investigate mechanisms of increased neutrophil adhesion in AATD and whether alpha-1 antitrypsin (AAT) augmentation therapy abrogates this effect. Plasma and blood neutrophils were donated by healthy controls (n = 20), AATD (n = 30), and AATD patients after AAT augmentation therapy (n = 6). Neutrophil membrane protein expression was investigated using liquid chromatography-tandem mass spectrometry. The effect of once-weekly intravenous AAT augmentation therapy was assessed by calcium fluorometric, µ-calpain, and cell adhesion assays. Decreased neutrophil plasma membrane cholesterol content (P = 0.03), yet increased abundance of integrin α-M (fold change 1.91), integrin α-L (fold change 3.76), and cytoskeletal adaptor proteins including talin-1 (fold change 4.04) were detected on AATD neutrophil plasma membrane fractions. The described inflammatory induced structural changes were a result of a more than twofold increased cytosolic calcium concentration (P = 0.02), leading to significant calcium-dependent µ-calpain activity (3.5-fold change; P = 0.005), resulting in proteolysis of the membrane cholesterol trafficking protein caveolin-1. Treatment of AAT-deficient individuals with AAT augmentation therapy resulted in increased caveolin-1 and membrane cholesterol content (111.8 ± 15.5 vs. 64.18 ± 7.8 µg/2 × 107 cells before and after treatment, respectively; P = 0.02), with concurrent decreased neutrophil integrin expression and adhesion. Results demonstrate an auxiliary benefit of AAT augmentation therapy, evident by a decrease in circulating inflammation and controlled neutrophil adhesion.


Subject(s)
Pulmonary Emphysema , alpha 1-Antitrypsin Deficiency , Calcium/metabolism , Caveolin 1/metabolism , Cholesterol/metabolism , Humans , Inflammation/metabolism , Integrins/metabolism , Neutrophils/metabolism , Pulmonary Emphysema/metabolism , alpha 1-Antitrypsin/metabolism
2.
ERJ Open Res ; 7(4)2021 Oct.
Article in English | MEDLINE | ID: mdl-34881324

ABSTRACT

Oxidative stress from innate immune cells is a driving mechanism that underlies COPD pathogenesis. Individuals with α-1 antitrypsin (AAT) deficiency (AATD) have a dramatically increased risk of developing COPD. To understand this further, the aim of this study was to investigate whether AATD presents with altered neutrophil NADPH oxidase activation, due to the specific lack of plasma AAT. Experiments were performed using circulating neutrophils isolated from healthy controls and individuals with AATD. Superoxide anion (O2 -) production was determined from the rate of reduction of cytochrome c. Quantification of membrane NADPH oxidase subunits was performed by mass spectrometry and Western blot analysis. The clinical significance of our in vitro findings was assessed in patients with AATD and severe COPD receiving intravenous AAT replacement therapy. In vitro, AAT significantly inhibited O2 - production by stimulated neutrophils and suppressed receptor stimulation of cyclic adenosine monophosphate and extracellular signal-regulated kinase (ERK)1/2 phosphorylation. In addition, AAT reduced plasma membrane translocation of cytosolic phox components of the NADPH oxidase. Ex vivo, AATD neutrophils demonstrated increased plasma membrane-associated p67phox and p47phox and significantly increased O2 - production. The described variance in phox protein membrane assembly was resolved post-AAT augmentation therapy in vivo, the effects of which significantly reduced AATD neutrophil O2 - production to that of healthy control cells. These results expand our knowledge on the mechanism of neutrophil-driven airways disease associated with AATD. Therapeutic AAT augmentation modified neutrophil NADPH oxidase assembly and reactive oxygen species production, with implications for clinical use in conditions in which oxidative stress plays a pathogenic role.

3.
Neurobiol Dis ; 149: 105227, 2021 02.
Article in English | MEDLINE | ID: mdl-33347976

ABSTRACT

Epileptogenesis, the gradual process that leads to epilepsy after brain injury or genetic mutations, is a complex network phenomenon, involving a variety of morphological, biochemical and functional brain alterations. Although risk factors for developing epilepsy are known, there is currently no treatment available to prevent epilepsy. We recently proposed a multitargeted, network-based approach to prevent epileptogenesis by rationally combining clinically available drugs and provided first proof-of-concept that this strategy is effective. Here we evaluated eight novel rationally chosen combinations of 14 drugs with mechanisms that target different epileptogenic processes. The combinations consisted of 2-4 different drugs per combination and were administered systemically over 5 days during the latent epileptogenic period in the intrahippocampal kainate mouse model of acquired temporal lobe epilepsy, starting 6 h after kainate. Doses and dosing intervals were based on previous pharmacokinetic and tolerability studies in mice. The incidence and frequency of spontaneous electrographic and electroclinical seizures were recorded by continuous (24/7) video linked EEG monitoring done for seven days at 4 and 12 weeks post-kainate, i.e., long after termination of drug treatment. Compared to vehicle controls, the most effective drug combination consisted of low doses of levetiracetam, atorvastatin and ceftriaxone, which markedly reduced the incidence of electrographic seizures (by 60%; p<0.05) and electroclinical seizures (by 100%; p<0.05) recorded at 12 weeks after kainate. This effect was lost when higher doses of the three drugs were administered, indicating a synergistic drug-drug interaction at the low doses. The potential mechanisms underlying this interaction are discussed. We have discovered a promising novel multitargeted combination treatment for modifying the development of acquired epilepsy.


Subject(s)
Anticonvulsants/administration & dosage , Atorvastatin/administration & dosage , Ceftriaxone/administration & dosage , Drug Delivery Systems/methods , Epilepsy/drug therapy , Levetiracetam/administration & dosage , Animals , Drug Evaluation, Preclinical/methods , Drug Therapy, Combination , Electroencephalography/drug effects , Electroencephalography/methods , Epilepsy/chemically induced , Epilepsy/physiopathology , Kainic Acid/toxicity , Male , Mice , Treatment Outcome
4.
Sci Rep ; 9(1): 12669, 2019 09 03.
Article in English | MEDLINE | ID: mdl-31481723

ABSTRACT

Agmatine (decarboxylated arginine) exerts numerous central nervous system (CNS) dependent pharmacological effects and may potentially modulate altered neurochemistry seen in neurological disorders. In preclinical studies, injection has been the predominant route of systemic administration. However, a significant translational step would be the use of oral agmatine treatment at therapeutic doses and better understanding of L-arginine metabolic profiles in the CNS post-treatment. The present study systematically investigated the tolerability, safety and brain-plasma neurochemistry following daily oral agmatine sulfate treatment (via gavage) to wild-type (WT) mice up to 900 mg/kg for one week (Experiment 1) or WT and APPswe/PS1ΔE9 transgenic (Tg) mice at 300 mg/kg for fifteen weeks (Experiment 2). Agmatine treatment in both experiments was well tolerated with no marked behavioural impairments, and gross necropsy and organ histology revealed no pathological alterations after 15-week dosing. Moreover, oral treatment increased agmatine levels in the hippocampus and plasma of WT mice (Experiment 1), and in 6 brain regions examined (but not plasma) of WT and Tg mice (Experiment 2), at 30 minutes or 24 hours post-treatment respectively. This study provides fundamental pre-clinical evidence that daily oral delivery of agmatine sulfate to both WT and Tg mice is safe and well tolerated. Exogenous agmatine passes through the blood brain barrier and accumulates in the brain to a greater extent in Tg mice. Furthermore exogenous agmatine has differential actions in the brain and periphery, and its effect on brain putrescine appears to be dependent on the time post-treatment.


Subject(s)
Agmatine/pharmacology , Brain/drug effects , Administration, Oral , Agmatine/blood , Amyloid beta-Protein Precursor/genetics , Animals , Arginine/blood , Arginine/metabolism , Behavior, Animal/drug effects , Blood-Brain Barrier/metabolism , Brain/metabolism , Brain/pathology , Female , Hippocampus/chemistry , Hippocampus/drug effects , Hippocampus/metabolism , Male , Mice , Mice, Transgenic
5.
IEEE Trans Ed ; 62(1): 48-56, 2019 Feb.
Article in English | MEDLINE | ID: mdl-35573982

ABSTRACT

Contribution: This paper demonstrates curricular modules that incorporate engineering model-based approaches, including concepts related to circuits, systems, modeling, electrophysiology, programming, and software tutorials that enhance learning in undergraduate neuroscience courses. These modules can also be integrated into other neuroscience courses. Background: Educators in biological and physical sciences urge incorporation of computation and engineering approaches into biology. Model-based approaches can provide insights into neural function; prior studies show these are increasingly being used in research in biology. Reports about their integration in undergraduate neuroscience curricula, however, are scarce. There is also a lack of suitable courses to satisfy engineering students' interest in the challenges in the growing area of neural sciences. Intended Outcomes: (1) Improved student learning in interdisciplinary neuroscience; (2) enhanced teaching by neuroscience faculty; (3) research preparation of undergraduates; and 4) increased interdisciplinary interactions. Application Design: An interdisciplinary undergraduate neuroscience course that incorporates computation and model-based approaches and has both software- and wet-lab components, was designed and co-taught by colleges of engineering and arts and science. Findings: Model-based content improved learning in neuroscience for three distinct groups: 1) undergraduates; 2) Ph.D. students; and 3) post-doctoral researchers and faculty. Moreover, the importance of the content and the utility of the software in enhancing student learning was rated highly by all these groups, suggesting a critical role for engineering in shaping the neuroscience curriculum. The model for cross-training also helped facilitate interdisciplinary research collaborations.

6.
J Genet Psychol ; 179(6): 357-370, 2018.
Article in English | MEDLINE | ID: mdl-30526436

ABSTRACT

The authors examined Grade 3 and Grade 5 teacher-rated classroom engagement and student self-reported motivation for reading as predictors of reading achievement. They investigated the patterns of prediction of achievement for three racial/ethnic groups (White, Black, and Hispanic) and five levels of socioeconomic status (SES) in a combined within-group model. Groups were created by crossing race/ethnicity with SES to form 15 independent groups for each grade level. Results indicated that self-reported motivation was a significant predictor of reading achievement mainly for White third-grade students; teacher-reported engagement was a better predictor for all racial/ethnic groups for both Grade 3 and Grade 5 reading achievement. Results show higher achievement for White and higher-SES students compared with non-White and lower-SES students.


Subject(s)
Academic Success , Black or African American/ethnology , Hispanic or Latino/psychology , Motivation , Reading , Social Class , Students/psychology , White People/ethnology , Child , Female , Humans , Male
7.
J Undergrad Neurosci Educ ; 16(3): A197-A202, 2018.
Article in English | MEDLINE | ID: mdl-30254531

ABSTRACT

We developed an interdisciplinary course in computational neuroscience to address the need for students trained in both biological/psychological and quantitative sciences. Increasingly, exposure to advanced math and physics is important to stay on the cutting edge of developments and research in neuroscience. Additionally, the ability to work in multidisciplinary teams will continue to be an asset as the field develops. This course brings together students from biology, psychology, biochemistry, engineering, physics, and mathematics. The course was designed to highlight the importance of math in understanding fundamental neuroscience concepts and to prepare students for professional careers in neuroscience. They learn neurobiology, via a 'biology to model and back again' approach involving wet- and software/modeling-labs, with the latter being the focus of this paper. We presented a subset of the software activities described here at the 2017 Faculty for Undergraduate Neuroscience Workshop.

8.
J Asthma Allergy ; 10: 209-223, 2017.
Article in English | MEDLINE | ID: mdl-28794645

ABSTRACT

Heterogeneity of asthma and difficulty in achieving optimal control are the major challenges in the management of asthma. To help attain the best possible clinical outcomes in patients with asthma, several guidelines provide recommendations for patients who will require a referral to a specialist. Such referrals can help in clearing the uncertainty from the initial diagnosis, provide tailored treatment options to patients with persistent symptoms and offer the patients access to health care providers with expertise in the management of the asthma; thus, specialist referrals have a substantial impact on disease prognosis and the patient's health status. Hurdles in implementing these recommendations include lack of their dissemination among health care providers and nonadherence to these guidelines; these hurdles considerably limit the implementation of specialist referrals, eventually affecting the rate of referrals. In this review, recommendations for specialist referrals from several key international and national asthma guidelines and other relevant published literature are evaluated. Furthermore, we highlight why referrals are not happening, how this can be improved, and ultimately, what should be done in the specialist setting, based on existing evidence in published literature.

9.
Inflammation ; 39(1): 425-433, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26433579

ABSTRACT

Rosacea is a chronic inflammatory condition that predominantly affects the skin of the face. Sera from rosacea patients display elevated reactivity to proteins from a bacterium (Bacillus oleronius) originally isolated from a Demodex mite from a rosacea patient suggesting a possible role for bacteria in the induction and persistence of this condition. This work investigated the ability of B. oleronius proteins to activate neutrophils and demonstrated activation via the IP3 pathway. Activated neutrophils displayed increased levels of IP1 production, F-actin formation, chemotaxis, and production of the pro-inflammatory cytokines IL-1ß and IL-6 following stimulation by pure and crude B. oleronius protein preparations (2 µg/ml), respectively. In addition, neutrophils exposed to pure and crude B. oleronius proteins (2 µg/ml) demonstrated increased release of internally stored calcium (Ca(2+)), a hallmark of the IP3 pathway of neutrophil activation. Neutrophils play a significant role in the inflammation associated with rosacea, and this work demonstrates how B. oleronius proteins can induce neutrophil recruitment and activation.


Subject(s)
Bacterial Proteins/immunology , Inositol 1,4,5-Trisphosphate/metabolism , Mites/microbiology , Neutrophil Activation/immunology , Neutrophil Infiltration/immunology , Rosacea/immunology , Animals , Bacillus/immunology , Calcium/metabolism , Humans , Inositol Phosphates/metabolism , Interleukin-1beta/immunology , Interleukin-6/immunology , Neutrophils/immunology , Rosacea/microbiology , Skin/microbiology , Skin/pathology
10.
Mol Immunol ; 63(2): 550-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25453468

ABSTRACT

BACKGROUND: The chemokine interleukin-8 (CXCL8) is a key mediator of inflammation in airways of patients with cystic fibrosis (CF). Glycosaminoglycans (GAGs) possess the ability to influence the chemokine profile of the CF lung by binding CXCL8 and protecting it from proteolytic degradation. CXCL8 is maintained in an active state by this glycan interaction thus increasing infiltration of immune cells such as neutrophils into the lungs. As the CXCL8-based decoy PA401 displays no chemotactic activity, yet demonstrates glycan binding affinity, the aim of this study was to investigate the anti-inflammatory effect of PA401 on CXCL8 levels, and activity, in CF airway samples in vitro. METHODS: Bronchoalveolar lavage fluid (BALF) was collected from patients with CF homozygous for the ΔF508 mutation (n=13). CXCL8 in CF BALF pre and post exposure to PA401 was quantified by ELISA. Western blot analysis was used to determine PA401 degradation in CF BALF. The ex vivo chemotactic activity of purified neutrophils in response to CF airway secretions was evaluated post exposure to PA401 by use of a Boyden chamber-based motility assay. RESULTS: Exposure of CF BALF to increasing concentrations of PA401 (50-1000pg/ml) over a time course of 2-12h in vitro, significantly reduced the level of detectable CXCL8 (P<0.05). Interestingly, PA401 engendered release of CXCL8 from GAGs exposing the chemokine susceptible to proteolysis. Subsequently, a loss of PA401 was observed (P<0.05) due to proteolytic degradation by elastase like proteases. A 25% decrease in neutrophil chemotactic efficiency towards CF BALF samples incubated with PA401 was also observed (P<0.05). CONCLUSION: PA401 can disrupt CXCL8:GAG complexes, rendering the chemokine susceptible to proteolytic degradation. Clinical application of a CXCL8 decoy, such as PA401, may serve to decrease the inflammatory burden in the CF lung in vivo.


Subject(s)
Bronchoalveolar Lavage Fluid , Cystic Fibrosis/metabolism , Interleukin-8/metabolism , Recombinant Proteins/pharmacology , Chemotaxis/drug effects , Enzyme-Linked Immunosorbent Assay , Glycosaminoglycans/metabolism , Humans , Neutrophils/drug effects , Neutrophils/pathology , Proteolysis/drug effects , Young Adult
11.
J Immunol ; 193(8): 3978-91, 2014 Oct 15.
Article in English | MEDLINE | ID: mdl-25217166

ABSTRACT

Alpha-1 antitrypsin (AAT) deficiency (AATD) is characterized by neutrophil-driven lung destruction and early emphysema in a low AAT, and high neutrophil elastase environment in the lungs of affected individuals. In this study, we examined peripheral blood neutrophil apoptosis and showed it to be accelerated in individuals with AATD by a mechanism involving endoplasmic reticulum stress and aberrant TNF-α signaling. We reveal that neutrophil apoptosis in individuals homozygous for the Z allele (PiZZ) is increased nearly 2-fold compared with healthy controls and is associated with activation of the external death pathway. We demonstrate that in AATD, misfolded AAT protein accumulates in the endoplasmic reticulum of neutrophils, leading to endoplasmic reticulum stress and the expression of proapoptotic signals, including TNF-α, resulting in increased apoptosis and defective bacterial killing. In addition, treatment of AATD individuals with AAT augmentation therapy decreased neutrophil ADAM-17 activity and apoptosis in vivo and increased bacterial killing by treated cells. In summary, this study demonstrates that AAT can regulate neutrophil apoptosis by a previously unidentified and novel mechanism and highlights the role of AAT augmentation therapy in ameliorating inflammation in AATD.


Subject(s)
Apoptosis/immunology , Emphysema/immunology , Neutrophils/pathology , alpha 1-Antitrypsin Deficiency/drug therapy , alpha 1-Antitrypsin/therapeutic use , ADAM Proteins/biosynthesis , ADAM17 Protein , Adult , Aged , Emphysema/complications , Endoplasmic Reticulum/immunology , Endoplasmic Reticulum/pathology , Endoplasmic Reticulum Stress/immunology , Female , Humans , Inflammation/drug therapy , Inflammation/immunology , Leukocyte Elastase/biosynthesis , Leukocyte Elastase/metabolism , Lung/pathology , Lung Injury/drug therapy , Lung Injury/immunology , Lung Injury/pathology , Male , Middle Aged , Neutrophils/immunology , Protein Folding , Proteostasis Deficiencies/immunology , Pseudomonas aeruginosa/immunology , Signal Transduction/immunology , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/immunology
12.
Blood ; 124(7): 999-1009, 2014 Aug 14.
Article in English | MEDLINE | ID: mdl-24934256

ABSTRACT

Studies have endeavored to reconcile whether dysfunction of neutrophils in people with cystic fibrosis (CF) is a result of the genetic defect or is secondary due to infection and inflammation. In this study, we illustrate that disrupted function of the CF transmembrane conductance regulator (CFTR), such as that which occurs in patients with ∆F508 and/or G551D mutations, correlates with impaired degranulation of antimicrobial proteins. We demonstrate that CF blood neutrophils release less secondary and tertiary granule components compared with control cells and that activation of the low-molecular-mass GTP-binding protein Rab27a, involved in the regulation of granule trafficking, is defective. The mechanism leading to impaired degranulation involves altered ion homeostasis caused by defective CFTR function with increased cytosolic levels of chloride and sodium, yet decreased magnesium measured in CF neutrophils. Decreased magnesium concentration in vivo and in vitro resulted in significantly decreased levels of GTP-bound Rab27a. Treatment of G551D patients with the ion channel potentiator ivacaftor resulted in normalized neutrophil cytosolic ion levels and activation of Rab27a, thereby leading to increased degranulation and bacterial killing. Our results confirm that intrinsic alterations of circulating neutrophils from patients with CF are corrected by ivacaftor, thus illustrating additional clinical benefits for CFTR modulator therapy.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Cystic Fibrosis/metabolism , Neutrophils/metabolism , rab GTP-Binding Proteins/metabolism , Adult , Aminophenols/therapeutic use , Cell Degranulation/drug effects , Cell Degranulation/genetics , Cells, Cultured , Chlorides/metabolism , Cystic Fibrosis/drug therapy , Cystic Fibrosis/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Electrophoresis, Gel, Two-Dimensional , Female , Homeostasis/genetics , Humans , Immunoblotting , Magnesium/metabolism , Male , Mutation , Neutrophils/drug effects , Neutrophils/physiology , Protein Transport/drug effects , Proteome/genetics , Proteome/metabolism , Proteomics/methods , Quinolones/therapeutic use , Sodium/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Young Adult , rab27 GTP-Binding Proteins
13.
Pharm Res ; 31(10): 2735-47, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24867420

ABSTRACT

PURPOSE: Some patients are unable to generate the peak inspiratory flow rate (PIFR) necessary to de-agglomerate drug particles from dry powder inhalers (DPIs). In this study we tested the hypothesis that the acoustic parameters of an inhalation are related to the PIFR and hence reflect drug delivery. METHODS: A sensitivity analysis of the relationship of the acoustics of inhalation to simultaneously recorded airflow, in a cohort of volunteers (n = 92) was performed. The Next Generation Impactor (NGI) was used to assess in vitro drug delivery from salmeterol/fluticasone and salbutamol Diskus™ DPIs. Fine particle fraction, FPF, (<5 µm) was measured at 30-90 l/min for 2-6 s and correlated with acoustically determined flow rate (IFRc). In pharmacokinetic studies using a salbutamol (200 µg) Diskus™, volunteers inhaled either at maximal or minimal effort on separate days. RESULTS: PIFRc was correlated with spirometrically determined values (R (2) = 0.88). In in vitro studies, FPF increased as both flow rate and inhalation duration increased for the salmeterol/fluticasone Diskus™ (Adjusted R (2) = 0.95) and was proportional to flow rate only for the salbutamol Diskus™ (Adjusted R (2) = 0.71). In pharmacokinetic studies, blood salbutamol levels measured at 20 min were significantly lower when PIFRc was less than 60 l/min, p < 0.0001. CONCLUSION: Acoustically-determined PIFR is a suitable method for estimating drug delivery and for monitoring inhalation technique over time.


Subject(s)
Acoustics/instrumentation , Drug Delivery Systems/instrumentation , Dry Powder Inhalers , Inhalation/physiology , Inspiratory Capacity/physiology , Administration, Inhalation , Aerosols , Albuterol/administration & dosage , Albuterol/analogs & derivatives , Albuterol/blood , Albuterol/pharmacokinetics , Androstadienes/administration & dosage , Androstadienes/blood , Androstadienes/pharmacokinetics , Drug Combinations , Equipment Design , Fluticasone-Salmeterol Drug Combination , Humans
14.
Sch Psychol Q ; 29(4): 517-535, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24708283

ABSTRACT

Research on factors that may promote engagement is hampered by the absence of a measure of classroom-level engagement. Literature has suggested that engagement may have 3 dimensions--affective, behavioral, and cognitive. No existing engagement scales measure all 3 dimensions at the classroom level. The Classroom Engagement Inventory (CEI) was developed to fill this gap. In Study 1, exploratory and confirmatory factor analyses were conducted on data from 3,481 students from the 4th to 12th grade. The results suggested a 4-factor model of the CEI. Using these results, in Study 2 several items were revised and data were collected 1 year later from 4th to 12th grade students in the same school district as Study 1. Analyses were conducted on data from 3,560 students after data cleaning. A series of potential models was tested. The final results suggest a 5-factor 24-item CEI: (1) Affective Engagement, (2) Behavioral Engagement-Compliance, (3) Behavioral Engagement-Effortful Class Participation, (4) Cognitive Engagement, and (5) Disengagement. Results advance understanding of the construct of classroom engagement. The CEI fills a significant gap in measurement of engagement. The CEI is classroom level, measures multiple dimensions of engagement, uses self-report, is relatively short, and can be readily administered in classrooms from the 4th to 12th grade.


Subject(s)
Interpersonal Relations , Psychometrics/methods , Social Behavior , Social Participation/psychology , Students/psychology , Factor Analysis, Statistical , Female , Humans , Male , Missouri , Reproducibility of Results , Schools , Social Environment
15.
J Immunol ; 192(5): 2418-31, 2014 Mar 01.
Article in English | MEDLINE | ID: mdl-24477913

ABSTRACT

The T cell Ig and mucin domain-containing molecule (TIM) family of receptors have emerged as potential therapeutic targets to correct abnormal immune function in chronic inflammatory conditions. TIM-3 serves as a functional receptor in structural cells of the airways and via the ligand galectin-9 (Gal-9) can modulate the inflammatory response. The aim of this study was to investigate TIM-3 expression and function in neutrophils, focusing on its potential role in cystic fibrosis (CF) lung disease. Results revealed that TIM-3 mRNA and protein expression values of circulating neutrophils were equal between healthy controls (n = 20) and people with CF (n = 26). TIM-3 was detected on resting neutrophil membranes by FACS analysis, and expression levels significantly increased post IL-8 or TNF-α exposure (p < 0.05). Our data suggest a novel role for TIM-3/Gal-9 signaling involving modulation of cytosolic calcium levels. Via TIM-3 interaction, Gal-9 induced neutrophil degranulation and primed the cell for enhanced NADPH oxidase activity. Killing of Pseudomonas aeruginosa was significantly increased upon bacterial opsonization with Gal-9 (p < 0.05), an effect abrogated by blockade of TIM-3 receptors. This mechanism appeared to be Gram-negative bacteria specific and mediated via Gal-9/ LPS binding. Additionally, we have demonstrated that neutrophil TIM-3/Gal-9 signaling is perturbed in the CF airways due to proteolytic degradation of the receptor. In conclusion, results suggest a novel neutrophil defect potentially contributing to the defective bacterial clearance observed in the CF airways and suggest that manipulation of the TIM-3 signaling pathway may be of therapeutic value in CF, preferably in conjunction with antiprotease treatment.


Subject(s)
Cystic Fibrosis/immunology , Galectins/immunology , Lung/immunology , Membrane Proteins/immunology , Neutrophils/immunology , Pseudomonas aeruginosa/immunology , Cystic Fibrosis/microbiology , Cystic Fibrosis/pathology , Female , Hepatitis A Virus Cellular Receptor 2 , Humans , Lipopolysaccharides/immunology , Lung/microbiology , Lung/pathology , Male , Neutrophils/microbiology , Signal Transduction/immunology
16.
Sci Transl Med ; 6(217): 217ra1, 2014 Jan 01.
Article in English | MEDLINE | ID: mdl-24382893

ABSTRACT

Pathological inflammation and autoimmune disease frequently involve elevated neutrophil activity in the absence of infectious agents. Tumor necrosis factor-α (TNF-α) contributes to many of the problems associated with autoimmune diseases. We investigated the ability of serum α-1 antitrypsin (AAT) to control TNF-α biosynthesis and signaling in neutrophils and assessed whether AAT deficiency (AATD) is a TNF-α-related disease. In vitro studies demonstrate that serum AAT coordinates TNF-α intracellular signaling and neutrophil degranulation of tertiary and secondary granules via modulation of ligand-receptor interactions. AATD patients homozygous for the Z allele were characterized by increased activation of the TNF-α system, as demonstrated by increased membrane TNF-α levels and increased plasma concentrations of TNF receptor 1 and neutrophil-released secondary and tertiary granule proteins. The incidence of autoantibodies directed against degranulated lactoferrin and surface protein accessible to these antibodies was increased in ZZ-AATD, leading to an enhanced rate of neutrophil reactive oxygen species production. Treatment of ZZ-AATD individuals with AAT augmentation therapy resulted in decreased membrane TNF-α expression and plasma levels of granule antigenic proteins and immunoglobulin G class autoantibodies. These results provide a mechanism by which AAT augmentation therapy affects TNF-α signaling in the circulating neutrophil, indicating promising potential of this therapy for other TNF-α-related diseases.


Subject(s)
Autoimmunity/physiology , Cell Degranulation/physiology , Neutrophils/cytology , alpha 1-Antitrypsin/blood , Adolescent , Adult , Autoantibodies/immunology , Female , Humans , Lactoferrin/immunology , Male , Middle Aged , Signal Transduction , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/immunology , Young Adult , alpha 1-Antitrypsin/physiology
17.
J Proteome Res ; 13(2): 596-605, 2014 Feb 07.
Article in English | MEDLINE | ID: mdl-24328305

ABSTRACT

Alpha-1 antitrypsin (AAT) is the major physiological inhibitor of a range of serine proteases, and in the lung, it maintains a protease-antiprotease balance. AAT deficiency (AATD) is an autosomal co-dominant condition with the Z mutation being the most common cause. Individuals homozygous for Z (PiZZ) have low levels of circulating mutant Z-AAT protein leading to premature emphysematous lung disease. Extensive glycoanalysis has been performed on normal AAT (M-AAT) from healthy individuals and the importance of glycosylation in affecting the immune modulatory roles of AAT is documented. However, no glycoanalysis has been carried out on Z-AAT from deficient individuals to date. In this study, we investigate whether the glycans present on Z-AAT differ to those found on M-AAT from healthy controls. Plasma AAT was purified from 10 individuals: 5 AATD donors with the PiZZ phenotype and 5 PiMM healthy controls. Glycoanalysis was performed employing N-glycan release, exoglycosidase digestion and UPLC analysis. No difference in branched glycans was identified between AATD and healthy controls. However, a significant increase in both outer arm (α1-3) (p = 0.04) and core (α1-6) fucosylated glycans (p < 0.0001) was found on Z-AAT compared to M-AAT. This study has identified increased fucosylation on N-glycans of Z-AAT indicative of ongoing inflammation in AATD individuals with implications for early therapeutic intervention.


Subject(s)
Fucose/metabolism , Mutation , Polysaccharides/metabolism , alpha 1-Antitrypsin Deficiency/metabolism , alpha 1-Antitrypsin/metabolism , Adult , Case-Control Studies , Chromatography, Liquid , Electrophoresis, Gel, Two-Dimensional , Humans , Male , Middle Aged , Polysaccharides/chemistry , Spectrometry, Fluorescence , Tandem Mass Spectrometry , Young Adult , alpha 1-Antitrypsin/genetics
18.
Biomed Res Int ; 2013: 560141, 2013.
Article in English | MEDLINE | ID: mdl-24073410

ABSTRACT

Secretory leukoprotease inhibitor (SLPI) is an anti-inflammatory protein present in respiratory secretions. Whilst epithelial cell SLPI is extensively studied, neutrophil associated SLPI is poorly characterised. Neutrophil function including chemotaxis and degranulation of proteolytic enzymes involves changes in cytosolic calcium (Ca(2+)) levels which is mediated by production of inositol 1,4,5-triphosphate (IP3) in response to G-protein-coupled receptor (GPCR) stimuli. The aim of this study was to investigate the intracellular function of SLPI and the mechanism-based modulation of neutrophil function by this antiprotease. Neutrophils were isolated from healthy controls (n = 10), individuals with cystic fibrosis (CF) (n = 5) or chronic obstructive pulmonary disease (COPD) (n = 5). Recombinant human SLPI significantly inhibited fMet-Leu-Phe (fMLP) and interleukin(IL)-8 induced neutrophil chemotaxis (P < 0.05) and decreased degranulation of matrix metalloprotease-9 (MMP-9), hCAP-18, and myeloperoxidase (MPO) (P < 0.05). The mechanism of inhibition involved modulation of cytosolic IP3 production and downstream Ca(2+) flux. The described attenuation of Ca(2+) flux was overcome by inclusion of exogenous IP3 in electropermeabilized cells. Inhibition of IP3 generation and Ca(2+) flux by SLPI may represent a novel anti-inflammatory mechanism, thus strengthening the attractiveness of SLPI as a potential therapeutic molecule in inflammatory airway disease associated with excessive neutrophil influx including CF, non-CF bronchiectasis, and COPD.


Subject(s)
Anti-Inflammatory Agents/metabolism , Cystic Fibrosis/pathology , Inositol 1,4,5-Trisphosphate/biosynthesis , Intracellular Space/metabolism , Neutrophils/metabolism , Pulmonary Disease, Chronic Obstructive/pathology , Secretory Leukocyte Peptidase Inhibitor/metabolism , Adult , Anti-Inflammatory Agents/pharmacology , Calcium/metabolism , Cell Degranulation/drug effects , Chemotaxis/drug effects , Cystic Fibrosis/metabolism , Cytoskeleton/drug effects , Cytoskeleton/metabolism , Cytosol/drug effects , Cytosol/metabolism , Female , Humans , Immunologic Factors/metabolism , Immunologic Factors/pharmacology , Intracellular Space/drug effects , Male , Models, Biological , Neutrophil Activation/drug effects , Neutrophils/drug effects , Neutrophils/physiology , Oxidation-Reduction/drug effects , Pulmonary Disease, Chronic Obstructive/metabolism , Recombinant Proteins/pharmacology
19.
J Inflamm Res ; 6: 1-11, 2013.
Article in English | MEDLINE | ID: mdl-23426081

ABSTRACT

Bronchiectasis is an airway disease characterized by thickening of the bronchial wall, chronic inflammation , and destruction of affected bronchi. Underlying etiologies include severe pulmonary infection and cystic fibrosis (CF); however, in a substantial number of patients with non-CF-related bronchiectasis (NCFB), no cause is found. The increasing armamentarium of therapies now available to combat disease in CF is in stark contrast to the limited tools employed in NCFB. Our study aimed to evaluate similarities and differences in airway inflammatory markers in patients with NCFB and CF, and to suggest potential common treatment options. The results of this study show that NCFB bronchoalveolar lavage fluid samples possessed significantly increased NE activity and elevated levels of matrix metalloproteinases 2 (MMP-2) and MMP-9 compared to healthy controls (P < 0.01); however, the levels detected were lower than in CF (P < 0.01). Interleukin-8 (IL-8) concentrations were significantly elevated in NCFB and CF compared to controls (P < 0.05), but in contrast, negligible levels of IL-18 were detected in both NCFB and CF. Analogous concentrations of IL-10 and IL-4 measured in NCFB and CF were statistically elevated above the healthy control values (P < 0.05 and P < 0.01, respectively). These results indicate high levels of important proinflammatory markers in both NCFB and CF and support the use of appropriate anti-inflammatory therapies already employed in the treatment of CF bronchiectasis in NCFB.

20.
J Clin Endocrinol Metab ; 98(1): E33-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23162106

ABSTRACT

CONTEXT: Offspring birthweight is inversely associated with future maternal cardiovascular mortality, a relationship that has yet to be fully elucidated. Endothelial progenitor cells (EPCs) are thought to play a key role in vasculogenesis, and EPC numbers reflect cardiovascular risk. OBJECTIVE: Our objective was to ascertain whether EPC number or function was reduced in mothers of low-birthweight infants. DESIGN AND SETTING: This was a prospective cohort study in a general antenatal department of a university maternity hospital. PARTICIPANTS: Twenty-three mothers of small for gestational age (SGA) infants (birthweight < 10th centile) and 23 mothers of appropriate for gestational age (AGA) infants (birthweight ≥ 10th centile) were recruited. MAIN OUTCOME MEASURES: Maternal EPC number and function, conventional cardiovascular risk markers, and cord blood adiponectin were measured. RESULTS: Median EPC count was lower (294 vs. 367, P = 0.005) and EPC migration was reduced (0.91 vs. 1.59, P < 0.001) in SGA compared with AGA infants, with no difference in EPC adhesion (0.221 vs. 0.284 fluorescence units, P = 0.257). Maternal triglyceride levels were higher in SGA than AGA infants (0.98 vs. 0.78 mmol/liter, P = 0.006), but there was no difference in cholesterol, glucose, insulin, glycosylated hemoglobin, adiponectin, or blood pressure. There was a moderate monotone (increasing) relationship between birthweight and umbilical cord blood adiponectin (r = 0.475, P = 0.005). CONCLUSION: Giving birth to an SGA infant was associated with lower maternal EPC number and reduced migratory function. Cord blood adiponectin was significantly correlated with birthweight.


Subject(s)
Cardiovascular Diseases/etiology , Endothelial Cells/physiology , Hematopoietic Stem Cells/physiology , Infant, Low Birth Weight , Mothers , Neovascularization, Pathologic/complications , Placenta/blood supply , Adult , Cells, Cultured , Cohort Studies , Endothelial Cells/cytology , Female , Fetal Growth Retardation/etiology , Fetal Growth Retardation/physiopathology , Hematopoietic Stem Cells/cytology , Humans , Infant, Newborn , Infant, Small for Gestational Age/physiology , Placenta/pathology , Placenta Diseases/etiology , Placenta Diseases/physiopathology , Pregnancy , Prenatal Exposure Delayed Effects/etiology , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...